<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9204219</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35720728</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9204219</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnins.2022.905121</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>TABLE 1</table-label><table-caption>Demographic and clinical characteristics of patients with PD and HCs.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>TABLE 1</label><caption><p>Demographic and clinical characteristics of patients with PD and HCs.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">HCs (<italic>n</italic> = 50)</td><td valign="top" align="center" rowspan="1" colspan="1">PD (<italic>n</italic> = 50)</td><td valign="top" align="center" rowspan="1" colspan="1"><italic>T/Z</italic></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1">61.74 ± 6.17</td><td valign="top" align="center" rowspan="1" colspan="1">62.88 ± 9.06</td><td valign="top" align="center" rowspan="1" colspan="1">0.735</td><td valign="top" align="center" rowspan="1" colspan="1">0.464</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex (M/F)</td><td valign="top" align="center" rowspan="1" colspan="1">30/20</td><td valign="top" align="center" rowspan="1" colspan="1">32/18</td><td valign="top" align="center" rowspan="1" colspan="1">0.170</td><td valign="top" align="center" rowspan="1" colspan="1">0.680</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education (years)</td><td valign="top" align="center" rowspan="1" colspan="1">10.44 ± 3.68</td><td valign="top" align="center" rowspan="1" colspan="1">10.26 ± 3.30</td><td valign="top" align="center" rowspan="1" colspan="1">−0.257</td><td valign="top" align="center" rowspan="1" colspan="1">0.797</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease duration (years)</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">6.32 ± 4.63</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS-III</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">27.76 ± 11.79</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">H-Y stage<break/> MoCA scores</td><td valign="top" align="center" rowspan="1" colspan="1">–<break/> 28.20 ± 1.32</td><td valign="top" align="center" rowspan="1" colspan="1">1.41 ± 0.45<break/> 24.36 ± 2.86</td><td valign="top" align="center" rowspan="1" colspan="1">–<break/> −8.608</td><td valign="top" align="center" rowspan="1" colspan="1">–<break/> &lt;0.001</td></tr></tbody></table><table-wrap-foot><fn><p><italic>Data are represented as mean ± standard deviation. HC, healthy control; PD, Parkinson’s disease; M, male; F, female; UPDRS, Unified Parkinson’s Disease Rating Scale; H-Y, Hoehn-Yahr.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of patients with PD and HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td/><td valign="top" align="center">HCs (n = 50)</td><td valign="top" align="center">PD (n = 50)</td><td valign="top" align="center">T/Z</td><td valign="top" align="center">P</td></tr></thead><tbody><tr><td valign="top" align="left">Age</td><td valign="top" align="center">61.74 ± 6.17</td><td valign="top" align="center">62.88 ± 9.06</td><td valign="top" align="center">0.735</td><td valign="top" align="center">0.464</td></tr><tr><td valign="top" align="left">Sex (M/F)</td><td valign="top" align="center">30/20</td><td valign="top" align="center">32/18</td><td valign="top" align="center">0.170</td><td valign="top" align="center">0.680</td></tr><tr><td valign="top" align="left">Education (years)</td><td valign="top" align="center">10.44 ± 3.68</td><td valign="top" align="center">10.26 ± 3.30</td><td valign="top" align="center">−0.257</td><td valign="top" align="center">0.797</td></tr><tr><td valign="top" align="left">Disease duration (years)</td><td valign="top" align="center">–</td><td valign="top" align="center">6.32 ± 4.63</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">UPDRS-III</td><td valign="top" align="center">–</td><td valign="top" align="center">27.76 ± 11.79</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">H-Y stage MoCA scores</td><td valign="top" align="center">– 28.20 ± 1.32</td><td valign="top" align="center">1.41 ± 0.45 24.36 ± 2.86</td><td valign="top" align="center">– −8.608</td><td valign="top" align="center">– &lt;0.001</td></tr></tbody></table></div>Data are represented as mean ± standard deviation. HC, healthy control; PD, Parkinson’s disease; M, male; F, female; UPDRS, Unified Parkinson’s Disease Rating Scale; H-Y, Hoehn-Yahr.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>TABLE 2</table-label><table-caption>Brain region with significant difference in FC values between patients with PD and HCs.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>TABLE 2</label><caption><p>Brain region with significant difference in FC values between patients with PD and HCs.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Brain regions</td><td valign="top" align="center" colspan="3" rowspan="1">Peak MNI coordinates<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Peak <italic>t</italic>-value</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Cluster size (number of voxels)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">X</td><td valign="top" align="center" rowspan="1" colspan="1">Y</td><td valign="top" align="center" rowspan="1" colspan="1">Z</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">BA</td><td rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>PD &gt; HC</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right precuneus<break/> Left cuneus<break/> right angular gyrus</td><td valign="top" align="center" rowspan="1" colspan="1">16<break/> −16<break/> 45</td><td valign="top" align="center" rowspan="1" colspan="1">−50<break/> −54<break/> −60</td><td valign="top" align="center" rowspan="1" colspan="1">28<break/> 24<break/> 39</td><td valign="top" align="center" rowspan="1" colspan="1">6.51<break/> 5.26<break/> 6.03</td><td valign="top" align="center" rowspan="1" colspan="1">23<break/> 19<break/> 39</td><td valign="top" align="center" rowspan="1" colspan="1">236<break/> 257<break/> 153</td></tr></tbody></table><table-wrap-foot><fn><p><italic>The statistical threshold was set at the voxel level with p &lt; 0.01 for multiple comparisons using Gaussian random-field theory (two tailed, voxel-level p &lt; 0.01, GRF correction, cluster-level p &lt; 0.05). FC, functional connectivity; BA, Brodmann area; MNI, Montreal Neurological Institute; PD, Parkinson’s disease; HCs, healthy controls.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Brain region with significant difference in FC values between patients with PD and HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Brain regions</td><td valign="top" align="center" colspan="3">Peak MNI coordinates</td><td valign="top" align="center">Peak t-value</td><td/><td valign="top" align="center">Cluster size (number of voxels)</td></tr><tr><td/><td valign="top" align="center">X</td><td valign="top" align="center">Y</td><td valign="top" align="center">Z</td><td/><td valign="top" align="center">BA</td><td/></tr></thead><tbody><tr><td valign="top" align="left">PD &gt; HC</td><td/><td/><td/><td/><td/><td/></tr><tr><td valign="top" align="left">Right precuneus Left cuneus right angular gyrus</td><td valign="top" align="center">16 −16 45</td><td valign="top" align="center">−50 −54 −60</td><td valign="top" align="center">28 24 39</td><td valign="top" align="center">6.51 5.26 6.03</td><td valign="top" align="center">23 19 39</td><td valign="top" align="center">236 257 153</td></tr></tbody></table></div>The statistical threshold was set at the voxel level with p &lt; 0.01 for multiple comparisons using Gaussian random-field theory (two tailed, voxel-level p &lt; 0.01, GRF correction, cluster-level p &lt; 0.05). FC, functional connectivity; BA, Brodmann area; MNI, Montreal Neurological Institute; PD, Parkinson’s disease; HCs, healthy controls.</transformed-table></extracted-table></extracted-tables-set>